BMI Executive Institute has organized a fintech/biotech field seminar for EMBA participants from Vilnius and Brussels with a programme full of practical workshops, panel discussions and company visits. The goal of the seminar was to expose participants to the key areas of starting and growing new ventures andempowering their entrepreneurial mindset.
The seminar combined content sessions, delivered by Prof. Dr. Jan Brinckamann from ESADE Business School, that provided insights regarding how to professionally and systematically identify opportunities to create high growth ventures in the digital, fintech and biotech field. Participants further experienced these different topics through discussions with entrepreneurs, fintech and biotech experts, investors, and during company visits.
“We aim to provide a well-rounded experience to our EMBA participants. We are always looking to find the perfect balance between theoretical knowledge and practical cases in our EMBA curriculum, allowing our participants to easily transfer them to their companies. This is the first time we have organized a practical field seminar of such scale, and the positive feedback we received encourages us to continue in this direction”, says Austėja Andziulytė-Milašiūnienė, Director of EMBA Programmes at BMI Executive Institute.
The field seminar was very much intended to provide a strong practical experience for the attendees. During the 3 days BMI EMBA participants from both Vilnius and Brussels cohorts had met and interacted with 12 business leaders from fintech and biotech fields.
The first day mainly focussed on the fintech, enriched by the meeting with entrepreneurs and investors Alex Gibb and Evaldas Remeikis, who created high growth companies. After that everyone participated in the panel discussion “The Benefits of Failure” with Andrius Bičeika, Deputy CEO of Revolut, Mindaugas Mikalajūnas, CEO at SME Finance, and Agnė Selemonaitė, Deputy CEO and Chair of the Board at ConnectPay.
During the second day the programme centred around the biotech. We held a panel discussion “Biotech: Is It a New Goldmine?” with Giedrė Kvedaravičienė, Board Member & Vice-chair of American Chamber of Commerce in Lithuania, Juozas Nainys, CEO at Droplet Genomics, Monika Paulė, Co-Founder & CEO at CasZyme, and Agnė Vaitkevičienė, Executive Director at Lithuanian Biotechnology Association. The session was followed by workshops and a company visit to Northway Biotech, including the meeting with its founder and CEO prof. Vladas Algirdas Bumelis.
On the final day the participants explored the financing of high growth companies, followed by the meeting with venture capitalists Audrius Milukas, who is also BMI EMBA alumni, and Paulius Vilemas. The field seminar ended with participants presenting their analysis of high growth companies, which they worked on during the whole session.
Greta Morkūnaitė, EMBA Class 2022 participant says that the seminar well exceeded her expectations. “This seminar exposed the immense potential of start-ups, particularly fintech and biotech ventures, also highlighting the emerging trends of entrepreneurship today. Academic tips were enriched with real life experiences, including ups and downs, openly shared by the entrepreneurs, investors and managers in the field. After this 3-day course I identified additional possibilities for my company growth as well as set a long-term ambition for my career – that went far beyond the expectations.”
The next field seminar “Doing Business in EU” will be held in Brussels at the end of October, where our both EMBA cohorts from Vilnius and Brussels will meet again.